JNJ Johnson & Johnson

Price (delayed)

$145.24

Market cap

$382.35B

P/E Ratio

22.48

Dividend/share

$3.92

EPS

$6.46

Enterprise value

$401.14B

Sector: Healthcare
Industry: Drug Manufacturers - General
Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Highlights

JNJ's price to earnings (P/E) is 67% lower than its 5-year quarterly average of 69.1
The quick ratio has increased by 27% QoQ and by 26% YoY
Johnson & Johnson's debt has increased by 29% YoY and by 24% from the previous quarter
The gross profit is down by 2.2% YoY

Key stats

What are the main financial stats of JNJ
Market
Shares outstanding
2.63B
Market cap
$382.35B
Enterprise value
$401.14B
Valuations
Price to earnings (P/E)
22.48
Price to book (P/B)
5.93
Price to sales (P/S)
4.73
EV/EBIT
20.82
EV/EBITDA
15.21
EV/Sales
4.96
Earnings
Revenue
$80.86B
EBIT
$19.27B
EBITDA
$26.37B
Free cash flow
$18.31B
Per share
EPS
$6.46
Free cash flow per share
$6.95
Book value per share
$24.49
Revenue per share
$30.71
TBVPS
$33.95
Balance sheet
Total assets
$170.69B
Total liabilities
$106.22B
Debt
$37.76B
Equity
$64.47B
Working capital
$18.73B
Liquidity
Debt to equity
0.59
Current ratio
1.48
Quick ratio
1.17
Net debt/EBITDA
0.71
Margins
EBITDA margin
32.6%
Gross margin
65.7%
Net margin
21%
Operating margin
24.3%
Efficiency
Return on assets
10.6%
Return on equity
27.4%
Return on invested capital
33.2%
Return on capital employed
14.6%
Return on sales
23.8%
Dividend
Dividend yield
2.7%
DPS
$3.92
Payout ratio
60.7%

JNJ stock price

How has the Johnson & Johnson stock price performed over time

Financial performance

How have Johnson & Johnson's revenue and profit performed over time
Revenue
$80.86B
Gross profit
$53.11B
Operating income
$19.65B
Net income
$16.99B
Gross margin
65.7%
Net margin
21%
Johnson & Johnson's net margin has increased by 21% YoY and by 11% from the previous quarter
Johnson & Johnson's net income has increased by 20% YoY and by 12% QoQ
The gross profit is down by 2.2% YoY

Growth

What is Johnson & Johnson's growth rate over time

Valuation

What is Johnson & Johnson stock price valuation
P/E
22.48
P/B
5.93
P/S
4.73
EV/EBIT
20.82
EV/EBITDA
15.21
EV/Sales
4.96
JNJ's price to earnings (P/E) is 67% lower than its 5-year quarterly average of 69.1
The EPS has grown by 21% YoY and by 12% from the previous quarter
JNJ's price to book (P/B) is 12% more than its 5-year quarterly average of 5.3
JNJ's equity is up by 11% year-on-year and by 2.4% since the previous quarter
The price to sales (P/S) is 5% more than the 5-year quarterly average of 4.5 and 5% more than the last 4 quarters average of 4.5

Efficiency

How efficient is Johnson & Johnson business performance
The ROS has grown by 16% from the previous quarter and by 16% YoY
The return on assets has increased by 15% year-on-year and by 9% since the previous quarter
The company's return on equity rose by 15% YoY and by 9% QoQ
Johnson & Johnson's return on invested capital has increased by 10% YoY and by 8% QoQ

Dividends

What is JNJ's dividend history
DPS
$3.92
Dividend yield
2.7%
Payout ratio
60.7%
Recent dividends

Financial health

How did Johnson & Johnson financials performed over time
JNJ's total assets is 61% greater than its total liabilities
The quick ratio has increased by 27% QoQ and by 26% YoY
JNJ's current ratio is up by 18% since the previous quarter and by 17% year-on-year
Johnson & Johnson's debt is 41% less than its equity
Johnson & Johnson's debt has increased by 29% YoY and by 24% from the previous quarter
The company's debt to equity rose by 23% QoQ and by 18% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.